Piramal Critical Care Inc. ('PCC I'), a subsidiary of Piramal Pharma Limited, and Blue-Zone Technologies Ltd. have announced an agreement to collaborate on a full lifecycle technology for capturing and recycling waste anesthetic gases. This partnership aims to combine Blue-Zone's innovative capture, collection, and processing technology with Piramal's global manufacturing and marketing capabilities. The collaboration will initially focus on offering Blue-Zone's Phoenix Deltasorb® waste anesthetic gas capture systems to PCC's customers in Europe, specifically in France and Germany, pending European regulatory approval. Blue-Zone will manage the supply and use of these systems in healthcare facilities. PCC will then process the captured waste anesthetic gas using Blue-Zone's technology to produce Sevoflurane USP for human use in Canada. The parties anticipate expanding this initiative into additional geographies. Jeff Hampton, President and COO of Piramal Critical Care, stated that the partnership is a significant step towards reducing waste and minimizing environmental impact in healthcare. He emphasized Piramal Pharma's commitment to supporting clinicians and hospitals with solutions that balance clinical performance and environmental responsibility, ensuring patients receive critical care while advancing sustainable anesthesia practices.
